---
title: "Predictors of Seasonal Influenza and COVID-19 Vaccination Uptake in UK FluSurvey Participants (202"
id: "medrxiv-0-factors-associated-with-vaccination-against-seasonal-influenza-and-sars-cov-2"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-factors-associated-with-vaccination-against-seasonal-influenza-and-sars-cov-2"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.25.26361301v1?rss=1"
published_at: "2026-08-28T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Predictors of Seasonal Influenza and COVID-19 Vaccination Uptake in UK FluSurvey Participants (202
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-factors-associated-with-vaccination-against-seasonal-influenza-and-sars-cov-2
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.25.26361301v1?rss=1)
- **Published At:** 2026-08-28T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This preprint reports an analysis of FluSurvey participants in the UK aged 65 years and older who were eligible for both **seasonal influenza** and **SARS‑CoV‑2 (COVID-19) vaccination** during the 2023–2024 and 2024–2025 autumn–winter campaigns. - The study aimed to profile self-reported attitudes to influenza vaccination and to identify predictors of vaccine uptake for both influenza and COVID-19. - Descriptive analyses summarized motivations and barriers to influenza vaccination; common motivations included belonging to a risk group and wanting to reduce influenza risk, while common barriers included beliefs about building natural immunity and concerns about safety and adverse effects. - Logistic regression models evaluated associations between vaccination uptake and factors including age, sex, socioeconomic status, education, employment, transport, smoking and chronic conditions, adjusting for confounders. - The strongest and most consistent finding was mutual association between receipt of the two vaccines: individuals vaccinated against **COVID‑19** had substantially higher odds of receiving **influenza vaccination** in the same season, and vice versa (adjusted odds ratios reported for both seasons). - Reported adjusted odds ratios for the vaccine-pair associations were: aOR2023–2024 ≈ 13.90 (95% CI 9.28–21.17) and aOR2024–2025 ≈ 8.54 (95% CI 5.82–12.60) for COVID‑19 vaccination predicting influenza uptake; reciprocal estimates were similar. - Lower educational attainment was associated with lower odds of COVID‑19 vaccination (aOR2023–2024 = 0.59 [0.45–0.78]; aOR2024–2025 = 0.56 [0.39–0.79]). - Other associations were described as weaker or seasonally variable; the abstract does not provide detailed estimates for all covariates. - The study used de‑identified FluSurvey data and reports that participant-level data cannot be shared under the FluSurvey privacy notice; instructions for data access requests are provided. - Authors declare no competing interests and state that ethical approvals and participant consent procedures were followed; supplementary material and data/code links are referenced in the preprint record.
## Clinical Analysis & Structured Key Points
Factors associated with vaccination against Seasonal Influenza and SARS-CoV-2 in the UK among FluSurvey participants, 2023-2025. | medRxiv Skip to main content Factors associated with vaccination against Seasonal Influenza and SARS-CoV-2 in the UK among FluSurvey participants, 2023-2025. View ORCID Profile Lauren Remi Adams , Conall Watson , View ORCID Profile Rebecca E Green , Gavin Dabrera doi: https://doi.org/10.64898/2026.08.25.26361301 Lauren Remi Adams UKHSA Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Lauren Remi Adams For correspondence: lauren.adams{at}ukhsa.gov.uk Conall Watson UKHSA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Rebecca E Green UKHSA Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Rebecca E Green Gavin Dabrera UKHSA Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Seasonal Influenza and COVID-19 vaccination programmes are critical for reducing morbidity and mortality in older adults, yet uptake remains uneven across populations. We aimed to profile vaccination attitudes and examine predictors of COVID-19/influenza vaccination uptake among a UK participatory surveillance system - FluSurvey. We analysed FluSurvey data from participants aged ≥65 years who were eligible for both vaccines in the 2023-2024 and 2024-2025 Autumn - Winter seasonal campaigns. Descriptive analyses examined self-reported attitudes to influenza vaccination. Logistic regression examined factors (age, sex, socioeconomic status, education, employment, transport, smoking and chronic conditions) associated with influenza and COVID-19 vaccination uptake in each season, adjusting for confounders. Belonging to a risk group and reducing risk of influenza were frequently reported motivations for influenza vaccination, while building natural immunity and concerns around safety and adverse effects were frequently reported barriers. Individuals vaccinated against COVID-19 were more likely to receive an influenza vaccination (aOR2023-2024=13.90 [9.28-21.17]; aOR2024-2025=8.54 [5.82-12.60]), and vice-versa (aOR2023-2024=13.91 [9.30-21.19]; aOR2024-2025=8.52 [5.81-12.58]). Lower educational attainment was associated with lower odds of COVID-19 vaccination (aOR2023-2024=0.59 [0.45-0.78], aOR2024-2025: 0.56 [0.39-0.79]). Other results were weaker or demonstrated variation by season. Our findings highlight recent attitudes and barriers to influenza and COVID-19 vaccination among the FluSurvey cohort, which may inform approaches to improve vaccination coverage in the population. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The datasets used were de-identified prior to use in this study. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability Participant data are unable to be shared; participants accept a privacy notice on registration which does not permit the sharing of pseudonymized data for this purpose (UKHSA FluSurvey Privacy Notice | Flusurvey, accessed 25/08/2026). For specific data requests, please refer to https://www.gov.uk/government/publications/accessing-ukhsa-protected-data. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . Back to top Previous Next Posted August 28, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Factors associated with vaccination against Seasonal Influenza and SARS-CoV-2 in the UK among FluSurvey participants, 2023-2025. Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Factors associated with vaccination against Seasonal Influenza and SARS-CoV-2 in the UK among FluSurvey participants, 2023-2025. Lauren Remi Adams , Conall Watson , Rebecca E Green , Gavin Dabrera medRxiv 2026.08.25.26361301; doi: https://doi.org/10.64898/2026.08.25.26361301 Share This Article: Copy Citation Tools Factors associated with vaccination against Seasonal Influenza and SARS-CoV-2 in the UK among FluSurvey participants, 2023-2025. Lauren Remi Adams , Conall Watson , Rebecca E Green , Gavin Dabrera medRxiv 2026.08.25.26361301; doi: https://doi.org/10.64898/2026.08.25.26361301 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Epidemiology Subject Areas All Articles Addiction Medicine (612) Allergy and Immunology (892) Anesthesia (325) Cardiovascular Medicine (4754) Dentistry and Oral Medicine (474) Dermatology (406) Emergency Medicine (640) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1610) Epidemiology (15806) Forensic Medicine (32) Gastroenterology (1194) Genetic and Genomic Medicine (6970) Geriatric Medicine (726) Health Economics (1051) Health Informatics (4960) Health Policy (1422) Health Systems and Quality Improvement (1731) Hematology (578) HIV/AIDS (1329) Infectious Diseases (except HIV/AIDS) (16229) Intensive Care and Critical Care Medicine (1158) Medical Education (661) Medical Ethics (150) Nephrology (718) Neurology (7164) Nursing (361) Nutrition (1072) Obstetrics and Gynecology (1226) Occupational and Environmental Health (999) Oncology (3563) Ophthalmology (1032) Orthopedics (392) Otolaryngology (445) Pain Medicine (464) Palliative Medicine (139) Pathology (702) Pediatrics (1771) Pharmacology and Therapeutics (730) Primary Care Research (758) Psychiatry and Clinical Psychology (5816) Public and Global Health (9666) Radiology and Imaging (2372) Rehabilitation Medicine and Physical Therapy (1428) Respiratory Medicine (1238) Rheumatology (632) Sexual and Reproductive Health (762) Sports Medicine (572) Surgery (763) Toxicology (106) Transplantation (301) Urology (285)
## Related Clinical Research

- [FDA approves Moderna’s mRNA flu vaccine mFLUSIVA for adults 50+: what clinicians should know](https://medichelpline.com/clinical-feed/medical-news-today-0-moderna-s-mrna-flu-vaccine-approved-by-fda-when-is-it-available.md)
- [MMR vaccines: separating measles, mumps, rubella shots — myths and facts](https://medichelpline.com/clinical-feed/medical-news-today-0-should-the-measles-mumps-rubella-vaccines-be-separate-myths-vs-facts.md)
- [Ebola Preparedness: Addressing the Gap in Virus Species Research](https://medichelpline.com/clinical-feed/stat-news-9-opinion-we-prepared-for-ebola-but-not-this-ebola.md)
- [Bundibugyo Ebola outbreak reveals gaps in Ebola preparedness and need for pan-filovirus tools](https://medichelpline.com/clinical-feed/stat-news-1-opinion-we-prepared-for-ebola-but-not-this-ebola.md)
- [Incidence of RSV in Adults ≥50 Years in the Upper Midwest After COVID-19: Community Cohort Finding](https://medichelpline.com/clinical-feed/bmj-open-6-incidence-of-respiratory-syncytial-virus-in-adults-50-years-during-and.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.